ACACB and acute myeloid leukemia: The strong reliance on FAO in AML cells, even independently of exposure to treatment, can be at least partially explained by downregulation of prolyl hydroxylase domain 3 protein (PHD3), an upstream regulator of acetyl-coA carboxylase 2 (ACC2).